Breast Cancer Clinical Trials
SOLAR-1: A phase III randomized double-blind, placebo-controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment.
Development of a Method for Extraction and Analysis of Cell-Free Nucleic Acids from Urine – Open to all patients except those with any of the following conditions:
- Hepatitis B
- Hepatitis C
- Low Blood Pressure
For more information about Beverly Hills Cancer Center's comprehensive clinical research programs and trials currently available to patients, please contact us at (310) 432-8932 or click here to send in an inquiry.
Schedule a Consultation Today!
Your health is important, and we welcome the opportunity to help you heal.
To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or use our interactive Online Appointment Request Form.